• search
For Quick Alerts
For Daily Alerts

Oxford’s coronavirus vaccine AstraZeneca trial resumes after UK green light


New Delhi, Sep 12: Oxford's coronavirus vaccine AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the nod from British regulators, following a pause caused by a UK volunteer falling ill.

Representational Image

"Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so," the pharma giant said in a statement.

Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study.

However, SII on Wednesday said it was continuing with the trials and had not faced any issues.

SII's latest announcement also comes against the backdrop of the central drug regulator DCGI issuing a show-cause notice to SII for not informing it about AstraZeneca pausing the clinical trials of the Oxford vaccine candidate in other countries.

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials," SII said in a statement.

The Pune-based vaccine maker also said it is following instructions of the Drugs Controller General of India (DCGI), it added.

In the show-cause notice, DCGI V G Somani had asked SII as to why the permission granted for conducting phase 2 and 3 clinical trials of the vaccine candidate in the country be not suspended till patient safety is established.

For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X